miR-29a down-regulates DNMT3A and −3B in lung cancer cells47 and hepatocytes48 while targets TET in malignant hematopoietic cells49, hepatocellular carcinoma cells50, breast cancer cells and embryonic stem cells51,52. This evidence concerns the gene DNMT3A and lung cancer.